Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/1995
12/14/1995WO1995033457A1 Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
12/14/1995CA2192305A1 Conformationally constrained backbone cyclized peptide analogs
12/14/1995CA2191610A1 Ligands for induction of antigen specific apoptosis in t cells
12/14/1995CA2187531A1 Tachykinin (nk1) receptor antagonists
12/13/1995EP0686642A2 Modified guanidino and amidino thrombin inhibitors
12/13/1995EP0686154A1 Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof
12/13/1995EP0513149B1 Pyridylphenyl nitrogen heterocycle-substituted carbinols and derivatives thereof with anti-inflammatory activity
12/12/1995US5475113 Tetrahydronaphthyl and thiazole, oxazole or imidazole substituted ethene derivatives having retinoid-like activity, reduced skin toxicity and reduced teratogenecity
12/12/1995US5475034 Adminstering 3-benzoylphenylacetamide derivatives
12/12/1995US5475018 Antiinflammatory agent, antiarthritic agent; analgesics and antipyretics
12/12/1995US5475017 Diaryl-substituted heterocyclic compounds, drugs and cosmetics obtained therefrom
12/12/1995US5474995 Phenyl heterocycles as cox-2 inhibitors
12/12/1995US5474988 Analgesics, antiinflammatory agents
12/12/1995US5474987 Methods of using low molecular weight heparins treatment of pathological processes
12/12/1995US5474771 Inhibits T cell activation of B cells ; binds to epitope
12/12/1995US5474759 Non-chlorofluorocarbon aerosol formulations
12/12/1995CA1337717C Monoclonal antibodies against human necrosis factor (tnf) _ use thereof for detecting tnf in samples, and pharmaceutical compositions containing them
12/11/1995CA2151412A1 Modified guanidino and amidino thrombin inhibitors
12/07/1995WO1995032972A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF
12/07/1995WO1995032971A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
12/07/1995WO1995032970A1 (a)-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF
12/07/1995WO1995032948A1 Quinoline derivatives as tachykinin nk3 receptor antagonists
12/07/1995WO1995032945A1 Compositions and methods for treating mast-cell mediated conditions
12/07/1995WO1995032944A1 Succinyl hydroxamic acid, n-formyl-n-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors
12/07/1995WO1995032718A1 2-halo-2'-deoxyadenosine treatement for inflammatory bowel disease
12/07/1995WO1995032715A1 Nitric oxide donor composition and method for treatment of anal disorders
12/07/1995WO1995032627A1 Use of fas ligand to suppress lymphocyte-mediated immune responses
12/07/1995DE4419315A1 New hetero- and oxo-pyrrolizine derivs.
12/07/1995DE4419247A1 New pyrrolizine keto-acid, keto-ester and carboxamide derivs.
12/07/1995DE4419246A1 New hetero-aryl substd. pyrrolizine derivs.
12/07/1995CA2191745A1 [a]-annelated pyrrole derivatives and pharmaceutical uses thereof
12/06/1995EP0685479A1 Heterocyclylcarbonyl substituted benzofuranyl- and -thiophenyl-alkanecarboxyclic acid derivatives
12/06/1995EP0685476A1 Benzo(5,6)cycloheptapyridines, compositions and methods of use
12/06/1995EP0685475A1 Amino-benzofuryl-and thienyl-derivatives
12/06/1995EP0685474A1 Oxalylamino-benzofuran- and benzothienyl-derivatives
12/06/1995EP0684953A1 Adenosine kinase inhibitors comprising lyxofuranosyl derivatives
12/06/1995EP0684820A1 Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents
12/06/1995EP0593478B1 Leukotriene b 4 antagonists
12/06/1995EP0588850B1 N-hydroxyurea derivatives which inhibit lipoxygenase
12/06/1995EP0544819B1 Indole derivatives which inhibit leukotriene biosynthesis
12/06/1995EP0445255B1 Treatment of conditions and disease
12/06/1995EP0429542B1 Leukocyte adhesion inhibitor
12/05/1995US5473100 Hydroxamic acid derivative
12/05/1995US5473096 Substituted benzoate derivatives
12/05/1995US5473079 Process for preparing 2-arylbenzimidazole-5-sulfonic acids
12/05/1995US5473071 Process for the preparation of fused pyridine compounds
12/05/1995US5472982 Emulsified external treatment composition containing diclofenac sodium
12/05/1995US5472964 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
12/05/1995US5472939 Method of treating complement mediated disorders
12/05/1995CA2001194C Use of resiniferatoxin and analogues thereof to cause sensory afferent c-fiber and thermoregulatory desensitization
12/01/1995CA2150305A1 Heterocyclylcarbonyl substituted benzofuranyl- and -thiophenyl-alkanecarboxyclic acid derivatives
12/01/1995CA2150301A1 Oxalylamino-benzofuran-and benzothienyl-derivatives
12/01/1995CA2150300A1 Amino-benzofuryl- and thienyl-derivatives
11/1995
11/30/1995WO1995032285A2 Transgenic arthritic mice
11/30/1995WO1995032282A1 Interleukin-6 splice variant
11/30/1995WO1995032194A1 Synthesis of optically pure 4-alkenyl- or 4-alkanyl-2-hydroxytetronic acids
11/30/1995WO1995031991A2 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
11/30/1995WO1995031987A1 Use of pteridine derivatives as no-synthase inhibitors
11/30/1995WO1995031985A2 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
11/30/1995WO1995031984A1 Method and reagents for the treatment of rheumatoid arthritis
11/30/1995WO1995031968A1 Non-steroidal anti-inflammatory ophthalmic suspensions
11/30/1995DE4418096A1 Verwendung von Pteridin-Derivaten als Hemmstoffe der NO-Synthase The use of pteridine derivatives as inhibitors of NO synthase
11/30/1995CA2190468A1 Synthesis of optically pure 4-alkenyl- or 4-alkanyl-2-hydroxytetronic acids
11/30/1995CA2188582A1 Method and reagents for the treatment of rheumatoid arthritis
11/29/1995EP0684257A1 Pseudopeptide derivatives of neurokinines, process for their preparation and pharmaceutical compositions comprising them
11/29/1995EP0684241A1 N-pyridyl carboxamide derivatives, processes for their preparation and pharmaceutical compositions containing them
11/29/1995EP0684240A1 Hydroxamic acid derivatives with tricyclic substitution
11/29/1995EP0683781A1 Novel inhibitors of adenosine monophosphate deaminase
11/29/1995EP0683767A1 Azacyclic compounds, compositions containing them and their use as tachykinin antagonists
11/29/1995EP0632726A4 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability.
11/29/1995EP0359783B1 Treatment of autoimmune diseases by oral administration of autoantigens
11/28/1995US5470978 Process and intermediates for the preparation of excitatory amino acid receptor antagonists
11/28/1995US5470885 Respriatory, gastrointestinal
11/28/1995US5470882 Diphenylsulfide with urea and sulfonates
11/28/1995US5470871 Therapeutic compositions based on 1,2-dithiole-3-thione derivatives
11/28/1995US5470864 Glycine amide derivatives containing pyridine or pyridine-N-oxide, anticholesterol, antiinflammatory
11/28/1995US5470855 Certain heterocyclic thiazole derivatives and their therapeutic use
11/28/1995US5470844 Heterocyclic-NMDA antagonists
11/28/1995US5470843 Carbohydrate-containing polymers, their preparation and use
11/28/1995US5470842 Carbohydrate-based anti-inflammatory agents
11/28/1995US5470840 Anti-inflammatory compounds and compositions
11/28/1995US5470832 Inhibitors of geranylgeranyl-protein transferase
11/28/1995US5470825 Basophil granule proteins
11/28/1995US5470578 Antirheumatic composition
11/28/1995CA1337660C Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives
11/28/1995CA1337642C Neutrophil chemotactic factor, cloned cdna and monoclonal antibodies thereto
11/23/1995WO1995031566A1 Compositions and methods for targeting gene delivery vehicles
11/23/1995WO1995031543A1 Dna encoding the beta subunit of a mammalian 'maxi-k' potassium channel
11/23/1995WO1995031482A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof
11/23/1995WO1995031467A1 Monocyte chemotactic protein-4
11/23/1995WO1995031463A1 New antagonist compounds
11/23/1995WO1995031451A1 Novel compounds
11/23/1995WO1995031206A1 P75 tnf receptor promoters
11/23/1995WO1995031205A1 Sialic acid/fucose based medicaments
11/23/1995WO1995031203A1 Oral liquid alendronate formulations
11/23/1995WO1995031197A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
11/23/1995WO1995031193A1 Matrix system for the transdermal delivery of ibuprofen, and method for preparing same
11/23/1995DE4417865A1 Two component tumour therapy using necrosis inducing agent
11/23/1995CA2190262A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof
11/23/1995CA2189970A1 Matrix system for the transdermal delivery of ibuprofen, and method for preparing same